John Cox, EVP Pharmaceutical Oper & Technology at BIOGEN IDEC INC. (BIIB), sold 4,041 shares at $70.08 ($283K) on 2011-03-02, disclosed to the SEC on 2011-03-03.
Open-market sale of $283k BIIB by EVP Pharmaceutical Oper & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.08 | 2,483 | $174K | 61.4% |
| 2 | $70.11 | 1,458 | $102K | 36.1% |
| 3 | $70.45 | 100 | $7K | 2.5% |
| Total | $70.10 avg | 4,041 | $283K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |